Quote | Super Quote
Code 
Advanced Search
Fund Quote
RT
02820 GX CN BIOTECH
  • Underlying Asset:
  • Solactive China Biotech Index NTR
  • NAV: 
    (As at 23/12/2024)
  • 45.839
    Premium +0.44%

IOPV calculations as shown on ETNet website (the “data”) provided by ICE Data Indices, see ICE Terms of Use, and is updated during HK Exchange trading hours. Powered by Factset. IOPV is indicative and for reference purposes only. The Fund is not sponsored, endorsed, sold or marketed by ICE Data Indices, LLC, its affiliates (“ICE Data”) and ICE Data or its respective third party suppliers make no express or implied warranties, and hereby expressly disclaim all warranties of merchantability or fitness for a particular purpose with respect to the iNAV, IOPV, fund or any fund data included therein. In no event shall ICE Data have any liability for any special, punitive, direct, indirect, or consequential damages (including lost profits), even if notified of the possibility of such damages. You acknowledge that the data is provided for information only and should not be relied upon for any purpose.

Fund Overview
Investment Target To provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Solactive China Biotech Index NTR
Underlying Asset Solactive China Biotech Index NTR
Asset China
Base Currency RMB
Trading Currency HKD
Board Lot Size 50
Admission Fee 2,302
Yid --
Dividend Policy Annual
Short Sell Allowed
ETF Type Physical
Derivatives Issuer N/A
Listing Date 25/07/2019
Management Fee 0.68% p.a.
Stamp Duty Remission in full
Market Maker Flow Traders Hong Kong Limited
Mirae Asset Securities Co.
Ltd
Fund Manager Mirae Asset Global Investments (Hong Kong) Limited
Website www.globalxetfs.com.hk/funds/china-biotech-etf/
Prospectus PDF(Chinese Version)    PDF(English Version)
 
 
Fund Price Performance
Fund return performance is not including dividend.
Data updated on: 25/12/2024
 
 
Net Asset Value 45.839 HKD (As at 23/12/2024)
Trust Unit outstanding
(Million)		 7.550 (As at 23/12/2024)
Total Net Asset
(Million)		 325.504 RMB (As at 23/12/2024)
 
Remark: Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Net asset value is subjected to the latest information released by issuers and daily updated.
Beware of delayed calculation of Premium/Discount(%).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.